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Abstract CD98 is a multifunctional heterodimeric membrane
protein involved in the regulation of cell adhesion as well as
amino acid transport. We show that CD98 cross-linking
persistently activates Rap1 GTPase in a LFA-1-dependent
manner and induces LFA-1/ICAM-1-mediated cell adhesion in
lymphocytes. Specific phosphatidylinositol-3-kinase (PI3K) in-
hibitors suppressed both LFA-1 activation and Rap1GTP
generation, and abrogation of Rap1GTP by retroviral over-
expression of a specific Rap1 GTPase activating protein, SPA-1,
totally inhibited the LFA-1/ICAM-1-mediated cell adhesion.
These results suggest that CD98 cross-linking activates LFA-1
via the PI3K signaling pathway and induces accumulation of
Rap1GTP in a LFA-1-dependent manner, which in turn mediates
the cytoskeleton-dependent cell adhesion process. ß 2001 Fed-
eration of European Biochemical Societies. Published by Else-
vier Science B.V. All rights reserved.
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1. Introduction
CD98 is a heterodimeric membrane protein consisting of a
85 kDa glycosylated type II protein (H chain) and a 37 kDa
multi-spun transmembrane protein with amino acid transport
activity (L chain) [1^4]. There are multiple related ‘CD98 L
chains’ covalently linked to a common H chain depending on
tissues [5,6]. We have indicated that the H chain functions as a
‘chaperon’ for targeting the L chain to the plasma membrane
[4].
Several studies, on the other hand, have indicated that
CD98 is also involved in the regulation of cell adhesion
[7,8]. It was reported that anti-CD98 H chain antibody in-
duced cell aggregation and syncytium formation associated
with virus infection, which was mediated by K3L1 integrin
[7]. More recently, it was shown that the transfection of
CD98 H chain cDNA could reverse the dominant negative
e¡ect of the chimeric cytoplasmic domain of L1 integrin and
activate endogenous L1 integrin [8]. These results have sug-
gested that CD98 is involved in the regulation of integrin
functions, although underlying molecular mechanisms remain
largely unknown.
Rap1 is a Ras-related small GTPase that is activated by a
variety of distinct extracellular stimuli [9]. We have reported
that Rap1 plays important roles in the regulation of integrin-
mediated cell adhesion [10,11]. In the present study, we show
that cross-linking of CD98 increases the avidity of L2-integrin
LFA-1 for ICAM-1 and induces the LFA-1-mediated cell ad-
hesion, in which a phosphatidylinositol-3-kinase (PI3K)-de-
pendent activation of Rap1 plays crucial roles.
2. Materials and methods
2.1. Cells and culture
Normal mouse spleen cells were stimulated with Con A for 2 days
followed by the culture with IL 2 for 3 days without Con A. BAF3
(pro-B cells) and BAF3 transfected with human LFA-1 K (KL) and L2
chain cDNAs (BAF3/hLFA-1) [11] were cultured in the RPMI1640
medium supplemented with 5U1035 M 2-mercaptoethanol, 10% fetal
calf serum and 10% WEHI-3 conditioned medium.
2.2. Antibodies
The F(abP)2 fragment of a monoclonal antibody (moAb) for mouse
CD98 H chain, 14.37, was used for the stimulation of cells. Other
antibodies used were as follows; anti-human KL (TS1/22), anti-human
L2 chain (7E4, Immunotech Inc.), anti-mouse KL (KBA-1, FD441.1),
anti-mouse ICAM-1 (KAT-1), anti-mouse VCAM-1 (PS/2), anti-
FLAG (Sigma), anti-Rap1 (Transduction Laboratory), anti-phos-
pho-external signal-regulated kinase (anti-phospho-ERK) (Santa
Cruz Biotechnology), anti-phospho-AKT (New England Biolabs)
and anti-SPA-1 [10].
2.3. Retroviral transfection
BAF/hLFA-1 cells were infected with the retrovirus containing
Flag-tagged Spa-1 cDNA [10] in the presence of 10 Wg/ml polybrene
for 2 h and cultured in the medium supplemented with G418 for
2 weeks.
2.4. ICAM-1 adhesion assay
Cells were labeled with 2P, 7P-bis-(2-carboxyethyl)-5 carboxy£uores-
cein (Molecular Probes) and transferred into the microtiter wells pre-
coated with puri¢ed ICAM-1 (2 Wg/well). After 30 min incubation at
37‡C, non-adherent cells were removed by needle aspiration, and ad-
herent cells were determined using a £uorescence concentration ana-
lyzer (Idexx Corp., USA) [11].
2.5. Immunoblotting, immunostaining and £owcytometry
To detect Rap1 GTP, cells were lysed with lysis bu¡er (150 mM
NaCl, 50 mM Tris^HCl pH 7.6, 0.5% Triton X-100, protease inhib-
itors), and precipitated with the GST-RalGDS Rap1-binding domain
fusion protein conjugated with glutathione-bead at 0‡C for 2 h, fol-
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lowed by the blotting with anti-Rap1 antibody. [10]. Immunostaining
and £owcytometric analysis was done as before [4].
3. Results
3.1. Anti-CD98 H chain antibody induces cellular aggregation
mediated by LFA-1 and ICAM-1
Stimulation of the primary T cell blasts with a F(abP)2 frag-
ment of anti-CD98 H chain moAb (14.37) induced strong
cellular aggregation, which was signi¢cantly inhibited by
anti-LFA-1 or ICAM-1 moAbs (Fig. 1A). To con¢rm the
primary involvement of LFA-1, we employed BAF3 line
transfected with human (h) LFA-1, BAF/hLFA-1. Parental
BAF3 only marginally expressed LFA-1 with a high level of
ICAM-1, and was barely aggregated with the moAb (Fig. 1B,
a). In contrast, BAF/hLFA-1, which highly expressed hLFA-
1, exhibited strong cellular aggregation (Fig. 1B, b). The same
e¡ect was observed in independent BAF/hLFA-1 clones, the
degree of aggregation being correlated with the hLFA-1 ex-
pression levels (data not shown). As shown in Fig. 1C, aggre-
gation of BAF/hLFA-1 with the moAb was completely inhib-
ited by the ‘blocking’ anti-hLFA-1 (Fig. 1B, b) as well as anti-
mICAM1 (Fig. 1B, c), while anti-mVLA4 was without e¡ect
(Fig. 1B, d). Immunostaining analysis revealed that LFA-1
was indeed concentrated in the cell adhesion sites following
the stimulation with the moAb, whereas signi¢cant proportion
of LFA-1 was detected in the perinuclear region in addition to
the cell surface in the unstimulated BAF/hLFA-1 (Fig. 1D).
These results have indicated that the cross-linking of CD98
induces cellular aggregation mediated by the LFA-1 and
ICAM-1 interaction in lymphocytes.
3.2. CD98 cross-linking activates Rap1 GTPase in a
LFA-1-dependent manner
We have reported that exogenous expression of dominant
active Rap1, RapV12, results in the strong cellular aggrega-
tion of BAF/hLFA-1 [11]. This prompted us to examine the
possible role of endogenous Rap1 in the CD98-induced cell
Fig. 1. CD98-induced cell aggregation is mediated by the LFA-1/
ICAM-1 interaction. A: The primary T cell blasts were incubated
with normal hamster IgG (NHIg) (a) or 14.37 moAb (b^d) at 5 Wg/
ml for 4 h in the absence (b) or presence of anti-mouse LFA-1,
FD441.1 (c) or anti-ICAM-1 (d) moAb at 40 Wg/ml. B: Expression
pro¢les of LFA-1, ICAM-1, and CD98 in BAF3 (a) and BAF/
hLFA-1 (b). The cells were cultured in the presence of either NHIg
(left) or 14.37 moAb (right). C: BAF/hLFA-1 cells were pretreated
with medium (a), anti-human LFA-1 (b), anti-mouse ICAM-1 (c) or
anti-VCAM-1 (d) moAbs (each at 40 Wg/ml) for 30 min followed by
the incubation with 14.37 moAb at 5 Wg/ml for 4 h. D: BAF/
hLFA-1 cells incubated with NHIg (a) or 14.37 moAb (b) for 4 h
were cytospined without disturbing the aggregates and immuno-
stained with FITC anti-hLFA-1. Arrowheads indicate the cell sur-
face (left), and arrows the free cell surface (right).
Fig. 2. Anti-CD98 moAb activates Rap1 in a LFA-1-dependent
manner. A: BAF3 and BAF/hLFA-1 were incubated at 37‡C in the
absence or presence of WEHI-CM (IL 3). 14.37 moAb was included
in the culture for the indicated periods. Rap1 GTP and total Rap1
were detected as described in Section 2. Aliquots of the samples
were examined for the phosphorylated ERK and AKT. B: BAF/
hLFA-1 cells were preincubated with or without anti-LFA-1, TS1/
22 (40 Wg/ml), for 20 min followed by the addition of NHIg or
14.37 moAb (10 Wg/ml). Rap1 GTP was detected after an additional
30 min incubation. C: BAF/hLFA-1 cells were incubated at 37‡C in
the presence of NHIg, 14.37, or anti-CD18 (10 Wg/ml each) for
30 min, and Rap1GTP was detected.
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adhesion. As shown in Fig. 2A, 14.37 moAb induced the
generation of Rap1 GTP in BAF/hLFA-1, which persisted
for at least 60 min, whereas no signi¢cant Rap1 GTP was
detected in BAF3. On the other hand, the moAb induced
the transient ERK phosphorylation in both BAF3 and
BAF/hLFA-1 with an earlier peak than Rap1GTP (within
10 min). In fact, the degree of ERK phosphorylation was
signi¢cantly less in BAF/hLFA-1 than in BAF3 (Fig. 2A).
CD98 cross-linking also induced phosphorylation of AKT in
both cells (Fig. 2A). As shown in Fig. 3B, a ‘blocking’ moAb
for hLFA-1 completely inhibited the generation of Rap1GTP
by 14.37 moAb in BAF/hLFA-1, while an ‘activating’ moAb
for L2 chain (CD18) alone induced signi¢cant Rap1 activation
albeit less than 14.37 moAb (Fig. 2C).
3.3. LFA-1-mediated cell aggregation via CD98 cross-linking is
dependent on Rap1GTP
We then addressed whether activation of the endogenous
Rap1 was indeed involved in the cell aggregation process by
CD98 cross-linking. BAF/hLFA-1 over-expressing a speci¢c
Rap1 GTPase activating protein, SPA-1 [12], was prepared
by retroviral infection (Fig. 3A). BAF/hLFA-1/SPA-1 exhib-
ited no detectable generation of Rap1GTP following the 14.37
moAb stimulation, while those infected with an empty retro-
virus (LXSN) showed an increase in Rap1GTP (Fig. 3C). As
shown in Fig. 3B, BAF/hLFA-1/SPA-1 showed signi¢cantly
reduced activation of LFA-1 for ICAM-1 binding by 14.37
moAb as compared with the control (net increase, 8.0% vs.
22.3%). Furthermore, cellular aggregation by the moAb was
almost completely suppressed in BAF/hLFA-1/SPA-1 (Fig.
3D). These results have indicated that LFA-1-mediated aggre-
gation via CD98 stimulation depends on the endogenous gen-
eration of Rap1GTP, which additionally contributes to the
LFA-1 activation per se.
3.4. PI3K inhibitors suppress the LFA-1 activation,
Rap1 activation, and cell aggregation via CD98
We ¢nally sought the molecular links between CD98 and
Fig. 3. Retroviral overexpression of SPA-1 abrogates the cell aggre-
gation via CD98. A: BAF/hLFA-1 cells were infected with retrovi-
rus containing Flag-tagged Spa-1 cDNA and the expression of SPA-
1 was detected by immunoblotting. B: Fluorescence-labeled BAF/
hLFA-1/LXSN (open columns) and BAF/hLFA-1/Spa-1 (¢lled col-
umns) cells were plated on the ICAM-1-coated wells in the presence
of NHIg or 14.37 moAb for 30 min, and the speci¢c adhesion was
determined. C: BAF/hLFA-1/LXSN and BAF/hLFA-1/Spa-1 cells
were incubated with 14.37 moAb for the indicated periods, lysed,
and Rap1GTP as well as total Rap1 were detected. D: BAF/hLFA-
1/LXSN (a) and BAF/hLFA-1/Spa-1 (b) cells were incubated with
5 Wg/ml 14.37 moAb for 4 h.
Fig. 4. PI3K inhibitors suppress LFA-1 and Rap1 activation and
cell aggregation via CD98. A: Fluorescence-labeled BAF/hLFA-1
cells were pre-incubated for 15 min with medium, wortmannin (50
nM), Ly294002 (50 nM), or calphostin (250 nM), plated on the
ICAM-1-coated wells in the presence of 14.37 moAb for 30 min,
and adhered cells were quantitated. B: BAF/hLFA-1 cells were pre-
treated as above with medium, wortmannin, Ly294002, calphostin,
herbimycin A (10 WM) or cytochalasin D (2 Wg/ml), and then incu-
bated with 14.37 moAb for 30 min. Rap1GTP (upper lanes) and to-
tal Rap1 (lower lanes) were detected. C: BAF/hLFA-1 cells were
similarly preincubated with medium (a), wortmannin (b), Ly294002
(c), calphostin (d), herbimycin A (e), or cytochalasin D (f) followed
by the incubation with 14.37 moAb for 4 h.
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LFA-1 activation. As shown in Fig. 4A, a PI3K inhibitor,
wortmannin, completely abrogated the adhesion of BAF/
hLFA-1 to ICAM-1 in the presence of 14.37 moAb, and
another PI3K inhibitor, Ly294002, suppressed the adhesion
to the control level. Neither PKC inhibitor calphostin
(Fig. 4A) nor PTK inhibitor herbimycin A (data not shown)
a¡ected the LFA-1 activation. Conforming to the e¡ects
on activation of LFA-1, wortmannin totally suppressed the
generation of Rap1 GTP by 14.37 moAb and Ly294002 did
so nearly to the control level, while calphostin and herbimycin
A were without e¡ect (Fig. 4B). Both PI3K, but not other,
inhibitors strongly suppressed the cell aggregation by the
moAb (Fig. 4C). Cytochalasin D also inhibited the cell aggre-
gation via CD98, while it hardly a¡ected the Rap1 activation
per se (Fig. 4B), indicating the requirement of cytoskeletal
reorganization in the former but not the latter process. These
results have suggested strongly that a PI3K-mediated sig-
naling is involved in the initiation of LFA-1 activation
and Rap1GTP generation via CD98, which is compatible
with the increased AKT phosphorylation by the moAb (see
Fig. 2A).
4. Discussion
LFA-1 is involved in a number of important cellular inter-
actions including those between leukocytes and endothelial
cells for cell migration, T lymphocytes and antigen-presenting
cells (APC) for the initiation of immune response, and cyto-
toxic lymphocytes and target cells [13^15]. In resting leuko-
cytes, LFA-1 is mostly in the ‘inactive’ state with low ligand
a⁄nity, and is activated to the high a⁄nity state by various
stimulation, which appears to be associated with conforma-
tional changes of the extracellular domain [16,17]. Following
the activation, LFA-1 is redistributed on the plasma mem-
brane and clustered to form stable cell^cell adhesion in a cy-
toskeleton-dependent manner [16,17].
Present study has indicated that the cross-linking of CD98
induces not only activation of LFA-1 for ICAM-1 binding but
also cellular aggregation mediated by the LFA-1/ICAM-1 in-
teraction. Cross-linking of CD98 induced rather persistent
activation of Rap1 in BAF/hLFA-1 but not in parental
BAF3, while it induced ERK activation in both cell types.
Thus, Rap1 activation via CD98 was dependent on LFA-1.
Abrogation of Rap1 GTP accumulation by exogenous over-
expression of SPA-1 totally suppressed the cell aggregation by
the moAb. The results clearly indicated that the endogenous
Rap1GTP is a crucial mediator for the LFA-1-mediated cell
adhesion via CD98. Most recently, it has been reported that
the CD31-induced T cell adhesion via LFA-1 and VLA-4 to
ICAM-1 and VCAM-1 respectively is also mediated by the
activation of Rap1 [18].
Several distinct signaling pathways can mediate the ‘inside-
out’ signaling for integrin activation, including PKC, PI3K,
and small GTPases [19^21]. Present results revealed that the
activation of LFA-1 via CD98 was completely inhibited by
speci¢c PI3K inhibitors, strongly suggesting the involvement
of the PI3K signaling pathway. Furthermore, they profoundly
inhibited the generation of Rap1GTP and subsequent cell
aggregation as well. It was indicated that expression of dom-
inant active PI3K p110 subunit induced LFA-1 activation,
although it failed to cause the LFA-1-mediated adhesion
[11]. Exogenous RapV12, on the other hand, induced both
LFA-1 activation and cell adhesion [11]. Indeed, over-expres-
sion of SPA-1 signi¢cantly if not completely inhibited the
activation of LFA-1 via CD98 as well. We therefore propose
that Rap1GTP generated at the down-stream of LFA-1 acti-
vated via the PI3K pathway not only mediates the subsequent
cytoskeleton-dependent cell adhesion process but also further
ampli¢es the LFA-1 adhesiveness per se in the cells stimulated
through CD98, thereby forming a positive feedback loop. This
may explain the persistent and progressive cell adhesion in the
presence of anti-CD98 moAb.
At present, possible ligands for CD98 remain to be deter-
mined, but it was reported that macrophage-derived galectin
3, an e⁄cient molecular cross-linker, could bind to CD98 on
T cells [22]. CD98 plays signi¢cant roles in the interaction
between T cells and APC [23], in which LFA-1 is critically
involved [13]. It has been also reported that Rap1GTP is one
of the critical factors to determine the T cell responsiveness
[24]. Thus, present results may provide a clue to understand
the roles this classical antigen CD98 plays.
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